IFNA1 and hepatocellular carcinoma: In 27 patients with large HCC tumors and multiple intrahepatic metastases, Tanaka et al (97) performed IFN-α and TACE combination therapy following maximal liver tumor resection, and identified that this treatment strategy offered the possibility of long-term survival despite the late stage of the disease.